PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Discover Oncology0 citationsOpen Access

Bibliometric analysis of research trends and hotspots in immunotherapy biomarkers for non-small cell lung cancer from 2015 to 2024

View Full Paper
XMXiangnv MengZLZhongting LuFMFu Mi

Key Points

  • Identifying significant trends in immunotherapy biomarkers for lung cancer enhances understanding of treatment options, leading to potential breakthroughs.
  • Between 2015 and 2024, 85% of publications focus on novel biomarkers related to immunotherapy in non-small cell lung cancer.
  • Bibliometric analysis highlights growing interest in specific immunotherapy biomarkers, emphasizing areas for further investigation and development.
  • Highlighting research hotspots aids in directing future studies towards impactful discoveries, fostering advancements in lung cancer treatment.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Meng et al. (2026) studied this question.

synapsesocial.com/papers/69a75a03c6e9836116a1f781https://doi.org/10.1007/s12672-026-04436-z
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer2015 · 9,534 citations
  2. 2Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer2024 · 156 citations
  3. 3The immune contexture in human tumours: impact on clinical outcome2012 · 5,010 citations
  4. 4Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment2023 · 21 citations
  5. 5Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody2023 · 69 citations